Medium dose group:Medium dose of Guaxiexintong dropping pills

2 trials

Sponsors

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences

Conditions

Coronary Heart Disease

Early Phase 1

A multicenter, randomized, double-blind, multi-dose, parallel-controlled, phase II exploratory study on the treatment of chronic stable angina pectoris (sputum stasis and blockage) with Gua-Xie-Xin-Tong dropping pills

RecruitingChiCTR2000034329

Xiyuan Hospital, Chinese Academy of Chinese Medical SciencesCoronary Heart Disease

Start: 2020-06-29Updated: 2020-07-06

A multicenter, randomized, double-blind, multi-dose, parallel-controlled, phase II exploratory study on the treatment of chronic stable angina pectoris (sputum stasis and blockage) with Gua-Xie-Xin-Tong dropping pills

RecruitingITMCTR2000003451

Xiyuan Hospital, Chinese Academy of Chinese Medical SciencesCoronary Heart Disease

Start: 2020-06-29Updated: 2023-02-20